NeuroTx Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.69M
- Investors
-
6
NeuroTx General Information
Description
Developer of an advanced artificial intelligence-based technology designed to contribute to drug development digitally. The company's technology offers artificial intelligence-powered tailored digital therapeutics for the management of neuropsychological disorders, enabling healthcare professionals to treat mental health disorders with optimized systems.
Contact Information
Website
www.neurotx.krCorporate Office
- 132B, Korea University R&D Center, 145 Anam-ro
- Seongbuk-gu
- Seoul
- South Korea
Corporate Office
- 132B, Korea University R&D Center, 145 Anam-ro
- Seongbuk-gu
- Seoul
- South Korea
NeuroTx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 03-Apr-2023 | $1.69M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 01-Jul-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | $306K | $306K | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuroTx Patents
NeuroTx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260166259-A1 | System and method for providing personalized stimuli based on bio-signals | Pending | 12-Dec-2024 | ||
| US-12616835-B2 | Neurostimulation-based neurofeedback device using brain waves and heartbeat signals | Active | 17-Aug-2021 | ||
| US-20230054459-A1 | Neurostimulation-based neurofeedback device using brain waves and heartbeat signals | Active | 17-Aug-2021 | A61N1/0452 |
NeuroTx Signals
NeuroTx Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DAYLI Partners | Venture Capital | Minority | ||
| Kakao Ventures | Venture Capital | Minority | ||
| Smilegate Investment | Venture Capital | Minority | ||
| AJU IB Investment | Venture Capital | Minority | ||
| Mira Ventures | Venture Capital | Minority |
NeuroTx FAQs
-
When was NeuroTx founded?
NeuroTx was founded in 2015.
-
Where is NeuroTx headquartered?
NeuroTx is headquartered in Seoul, South Korea.
-
What is the size of NeuroTx?
NeuroTx has 7 total employees.
-
What industry is NeuroTx in?
NeuroTx’s primary industry is Enterprise Systems (Healthcare).
-
Is NeuroTx a private or public company?
NeuroTx is a Private company.
-
What is NeuroTx’s current revenue?
The current revenue for NeuroTx is .
-
How much funding has NeuroTx raised over time?
NeuroTx has raised $2.3M.
-
Who are NeuroTx’s investors?
DAYLI Partners, Kakao Ventures, Smilegate Investment, AJU IB Investment, and Mira Ventures are 5 of 6 investors who have invested in NeuroTx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process